Third Class Of Drugs Back In The News With Proposed UK Statin Switch
This article was originally published in The Tan Sheet
Executive Summary
J&J/Merck's application to make Zocor available in the UK without a prescription may revive debate in the U.S. regarding creation of a third class of drugs